.Nature Medication, Released online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparvovec received FDA confirmation after an unfavorable trial, which highlights the various complexities as well as problems of medicine advancement within this environment.